Reckitt Benckiser Group (LSE:RKT) has drawn fresh attention after appointing Guntas Randhawa as Regional Marketing Director for Health in South Asia, a move that puts its Dettol and Durex portfolios firmly in focus.
The latest 1-day share price return of 1.64% to £52.16 caps a stronger recent run for Reckitt Benckiser Group, with a 7-day share price return of 6.69% and a 30-day gain of 4.32%. However, the year-to-date share price is still down 16.29% and the 1-year total shareholder return is lower by 5.14%, which points to improving short-term momentum against a more muted longer-term record.
Scan how Reckitt Benckiser Group compares with other consumer giants by reviewing a curated list of solid balance sheet and fundamentals (9 results) that is already attracting attention from long-term investors.
Short term momentum is turning, while the longer term chart still shows scars. For Reckitt Benckiser Group, after this senior hire and mixed recent returns, does it make more sense to lean in now or wait for a cleaner entry point once the valuation work is done?
Most Popular Narrative: 15.6% Undervalued
On Simply Wall St's most followed narrative, Reckitt Benckiser Group screens as undervalued, with a fair value of £61.82 against the latest close at £52.16. The analysis places more weight on cash flows and margins than on the recent share price weakness.
The Fuel for Growth program is delivering fixed cost reductions and operational simplification ahead of plan, enabling greater reinvestment into brand marketing and innovation, which will likely create a virtuous cycle for further market share gains and improved earnings quality.
See why 69 investors see Reckitt Benckiser Group as 16% undervalued .
Result: Fair Value of £61.82 (UNDERVALUED)
Still, legal action around product safety in the US and slower category growth in developed markets could quickly challenge the current view that Reckitt Benckiser Group is undervalued.
Find out about the key risks to this Reckitt Benckiser Group narrative .
Next Steps
If the mix of risks and rewards around Reckitt Benckiser Group feels finely balanced, consider acting promptly and review the full picture for yourself with 5 key rewards and 3 important warning signs .
Looking for more Reckitt Benckiser Group style investment ideas?
If you want a clearer watchlist before the next move, use the Simply Wall St Screener to surface quality stocks by the traits that matter to you.
-
Target dependable cash generators by scanning companies that pass a rigorous balance sheet and fundamentals check through this focused list of solid balance sheet and fundamentals (9 results) .
-
Hunt for mispriced opportunities by lining up potential bargains using a curated 7 high quality undervalued stocks built from cash flow strength and balance sheet resilience.
-
Prioritise resilience first by reviewing a 4 resilient stocks with low risk scores that filters for businesses with lower risk scores so setbacks are less likely to knock your portfolio off track.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include RKT.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
